Cleared Special

K101067 - SURESIGNS VM4

K101067 is the FDA 510(k) clearance for SURESIGNS VM4 by Philips Medical Systems. It is a Class 2 Cardiovascular device (product code MHX) cleared through the Special 510(k) pathway after a 21-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2010
Decision
21d
Days
Class 2
Risk

K101067 is an FDA 510(k) clearance for the SURESIGNS VM4, SURESIGNS VM6, SURESIGNS VM8 MODEL: 863063, 863064, 863065, 86.... Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Philips Medical Systems (Andover, US). The FDA issued a Cleared decision on May 7, 2010 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Philips Medical Systems devices

Submission Details

510(k) Number K101067 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 16, 2010
Decision Date May 07, 2010
Days to Decision 21 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
104d faster than avg
Panel avg: 125d · This submission: 21d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 256
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K101067.
M3290B INTELLIVUE INFORMATION CENTER SOFTWARE, RELEASE A.0
K102495 · Philips Medical Systems · Sep 2010
BENEVIEW T SERIES PATIENT MONITORS, MODELS BENEVIEW T8, T6 AND T5
K092449 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Aug 2010
ST/AR ST AND ARRHYTHMIA SOFTWARE MODEL: RELEASE K.O
K101521 · Philips Medical Systems · Jul 2010
INFINITY ACUTE CARE SYSTEM (IACS) MONITORING SOLUTION
K093788 · Draeger Medical Systems, Inc. · Mar 2010
12SL ECG ANALYSIS PROGRAM
K092369 · Ge Medical Systems Information Technologies · Feb 2010
CARESCAPE MONITOR B850
K092027 · Ge Medical Systems Information Technologies · Aug 2009